CA1246065A - 5-(3,4-dihydrocarbostyril-6-yl)-3,6-dihydro-1,2,4- thiadiazin-2-one - Google Patents

5-(3,4-dihydrocarbostyril-6-yl)-3,6-dihydro-1,2,4- thiadiazin-2-one

Info

Publication number
CA1246065A
CA1246065A CA000493512A CA493512A CA1246065A CA 1246065 A CA1246065 A CA 1246065A CA 000493512 A CA000493512 A CA 000493512A CA 493512 A CA493512 A CA 493512A CA 1246065 A CA1246065 A CA 1246065A
Authority
CA
Canada
Prior art keywords
compound
dihydro
compounds
thiadiazin
cardiotonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000493512A
Other languages
English (en)
French (fr)
Inventor
Hideki Ao
Minoru Obata
Jun Inui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Application granted granted Critical
Publication of CA1246065A publication Critical patent/CA1246065A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA000493512A 1984-10-29 1985-10-22 5-(3,4-dihydrocarbostyril-6-yl)-3,6-dihydro-1,2,4- thiadiazin-2-one Expired CA1246065A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59227300A JPS61106574A (ja) 1984-10-29 1984-10-29 オキサ（またはチア）ジアジン誘導体
JP227300/84 1984-10-29

Publications (1)

Publication Number Publication Date
CA1246065A true CA1246065A (en) 1988-12-06

Family

ID=16858652

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000493512A Expired CA1246065A (en) 1984-10-29 1985-10-22 5-(3,4-dihydrocarbostyril-6-yl)-3,6-dihydro-1,2,4- thiadiazin-2-one

Country Status (8)

Country Link
US (1) US4678785A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0180158B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS61106574A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880002086B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE37369T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1246065A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3565104D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8701174A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0226641B1 (en) * 1985-05-25 1989-10-18 Yoshitomi Pharmaceutical Industries, Ltd. Oxodiazine compounds
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
EP0303418A3 (en) * 1987-08-11 1990-11-07 Smithkline Beecham Laboratoires Pharmaceutiques Substituted indolones, useful in the treatment of heart or asthmatic diseases
GB8816944D0 (en) * 1988-07-15 1988-08-17 Sobio Lab Compounds
GB8901836D0 (en) * 1989-01-27 1989-03-15 Sobio Lab Compounds
JPH02279685A (ja) * 1989-04-18 1990-11-15 Yoshitomi Pharmaceut Ind Ltd 新規な結晶構造を有するチアジアジン化合物およびその製造法
US5179203A (en) * 1990-07-31 1993-01-12 Yoshitomi Pharmaceutical Industries Ltd. Thiadiazine compound with a novel crystalline form
DE4041074A1 (de) * 1990-12-21 1992-06-25 Merck Patent Gmbh Thiadiazinonderivate
US6703537B1 (en) * 1997-11-15 2004-03-09 The Procter & Gamble Company Absorbent article having improved fecal storage structure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052442B1 (en) * 1980-11-14 1985-09-11 Imperial Chemical Industries Plc Heterocyclic compounds
CA1199027A (en) * 1981-11-12 1986-01-07 Stuart D. Mills Heterocyclic derivatives of pyridazinone, thiadiazinone, oxadiazinone and triazinone
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones

Also Published As

Publication number Publication date
KR860003247A (ko) 1986-05-21
DE3565104D1 (en) 1988-10-27
ATE37369T1 (de) 1988-10-15
JPH0129190B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-06-08
EP0180158A1 (en) 1986-05-07
KR880002086B1 (ko) 1988-10-15
JPS61106574A (ja) 1986-05-24
ES548330A0 (es) 1986-11-16
US4678785A (en) 1987-07-07
ES8701174A1 (es) 1986-11-16
EP0180158B1 (en) 1988-09-21

Similar Documents

Publication Publication Date Title
US4687777A (en) Thiazolidinedione derivatives, useful as antidiabetic agents
EP0005129B1 (en) Substituted pyridylsulfinylbenzimidazoles having gastric acid secretion properties, pharmaceutical preparations containing same, and intermediates for their preparation
CA1286669C (en) Aminoalkylphenoxy derivatives
CA1146555A (en) 2-alkoxyphenyl-imidazo[4,5-b]pyridines, their preparation and their use as pharmaceuticals
EP0264231A1 (en) Azetidinone derivatives
CA1246065A (en) 5-(3,4-dihydrocarbostyril-6-yl)-3,6-dihydro-1,2,4- thiadiazin-2-one
HU201955B (en) Process for producing new ribofuranuronic acid derivatives and pharmaceutical compositions comprising such compounds
KR900003368B1 (ko) 신규한 인데노티아졸 유도체의 제조방법
JPH02149579A (ja) ヘテロ環置換アルコキシクマリン、その製造方法およびこれを含有する治療剤
KR860001865B1 (ko) 2'-데옥시-5-치환 우리딘 유도체의 제조방법
HU203548B (en) Process for producing benzoxazine derivatives and pharmaceutical compositions containing them
JPS6377878A (ja) ４、５−ジヒドロ−オキサゾ−ルの新規誘導体、その製造方法及びその使用法
JPH02218689A (ja) アデノシン誘導体、その製法および用途
US4246260A (en) Substituted omicron-phenylenediamine derivatives, process for their preparation and their use as medicaments
US3426017A (en) Sulfonylurea compounds
EP0379737A2 (en) Dihydropyridine derivatives for the treatment of angiospasm
US5059607A (en) Imidazolyl benzisoquinolines useful as 5-ht3 receptor antagonists
CA1081228A (en) Oxazole, isoxazole, thiazole and isothiazole amides
US4755514A (en) Phenylpyrazine derivatives and thrombolytic agent
HU194863B (en) Process for producing 5-amino-1,2-dithiol-3-one derivatives and pharmaceutical compositions containing them
US3530124A (en) 4-(5-nitro-2-thiazolyl)-thiomorpholine-oxides
HUT61759A (en) Thiadiazinone derivatives, process for their producing and pharmaceutical compositions comprising same
JPH0215547B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2816974B2 (ja) ベンズイミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
US4544659A (en) Schistosomicidal acridanone hydrazones

Legal Events

Date Code Title Description
MKEX Expiry